Answers are grounded in this paper and cite their sources.
Emerging evidence suggests that preventing SARS-CoV-2 from entering and infecting host cells represents an effective strategy to limit viral infection, particularly in the context of its ongoing evolution. In this study, a small peptide fragment derived from major histocompatibility complex class I (MHC class I), designated MH-1, was investigated for its ability to interfere with the early stages of SARS-CoV-2 infection. Molecular docking was used to characterize the interaction between MH-1 and the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein. The inhibitory effect of MH-1 on S protein–ACE2 binding was further evaluated using an ACE2-functionalized electrochemical impedance spectroscopy (EIS) biosensing platform. Antiviral efficacy was assessed using SARS-CoV-2 S-pseudotyped lentiviruses and SARS-CoV-2 variants in different human cells. In vivo inhibitory efficacy of MH-1 was assessed in the K18-hACE2 mouse model, followed by lung viral load measurement and histopathological assessment. MH-1 peptide interacted with the S-RBD and disrupted S protein-ACE2 binding. MH-1 effectively reduced SARS-CoV-2 infection in cells that expressed different levels of ACE2 and TMPRSS2. Furthermore, MH-1 decreased the infection of SARS-CoV-2 in T lymphocytes that highly express HLA-C but have low levels of ACE2 and TMPRSS2. In animal studies, MH-1 reduced the viral load in the lungs of K18-hACE2 mice and reduced the infiltration of immune cells, including macrophages and T cells, into the lungs. Levels of lung damage and inflammatory cytokines were also reduced by MH-1 and restored to normal. These findings identify MH-1 as a promising prophylactic or early-stage intervention that inhibits SARS-CoV-2 infection by interfering with spike-mediated infection of pulmonary and immune cells.
No takes yet. Share an insight, caveat, or question.
Jian et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: